文献速递区域麻醉与超声疼痛医学

全髋关节置换术:PENG阻滞与关节周围局部麻醉浸润的随机临床试验比较

Randomized clinical trial comparing pericapsular nerve group (PENG) block and periarticular local anesthetic infiltration for total hip arthroplasty.
PubMed 文献 · Reg Anesth Pain Med · 2023-02-16

这项随机试验比较了全髋关节置换术中PENG阻滞与关节周围局部麻醉浸润,主要假设是后者将3小时股四头肌无力发生率降低五倍。结果显示两组3小时股四头肌无力无差异(20% vs 33%;p=0.469),但关节周围浸润组静态疼痛评分(所有测量间隔)和动态疼痛评分(3和6小时)更低。

要点

  • PENG阻滞与关节周围浸润的3小时股四头肌无力发生率无显著差异。
  • 关节周围浸润组在全部测量间隔的静态疼痛评分更低。
  • 关节周围浸润组在3和6小时的动态疼痛评分更低。

核心结论

  • 对于初次全髋关节置换术,PENG阻滞与关节周围局部麻醉浸润导致相当的股四头肌无力发生率。
  • 关节周围局部麻醉浸润与更低的静态疼痛评分(尤其最初24小时)和动态疼痛评分(最初6小时)相关。
  • 需要进一步研究以确定关节周围局部麻醉浸润的最佳技术和局部麻醉药混合物。

研究设计与样本

  • 随机临床试验,纳入60例在脊髓麻醉下接受初次全髋关节置换术的患者。
  • 患者随机接受PENG阻滞(n=30,0.50%肾上腺化布比卡因20 mL)或关节周围局部麻醉浸润(n=30,0.25%肾上腺化布比卡因60 mL)。
  • 两组均接受酮咯酸30 mg(PENG组静脉注射,浸润组关节周围注射)以及地塞米松4 mg静脉注射。

主要发现

  • 3小时股四头肌无力发生率PENG组为20%,关节周围浸润组为33%(p=0.469)。
  • 其他时间间隔的感觉阻滞或运动阻滞、首次阿片类药物请求时间、累积突破性吗啡消耗量、阿片相关副作用、物理治疗能力和住院时间均无组间差异。
  • 与PENG阻滞相比,关节周围局部麻醉浸润导致更低的静态疼痛评分(所有测量间隔)和动态疼痛评分(3和6小时)。

临床怎么用

  • 对于初次全髋关节置换术,PENG阻滞和关节周围局部麻醉浸润均可考虑,两者股四头肌无力发生率相当。
  • 若优先考虑降低术后早期静态和动态疼痛评分,关节周围局部麻醉浸润可能更优。

局限性

  • 需要进一步研究以确定关节周围局部麻醉浸润的最佳技术和局部麻醉药混合物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This randomized trial compared pericapsular nerve group block and periarticular local anesthetic infiltration in patients undergoing primary total hip arthroplasty. We hypothesized that, compared with pericapsular nerve group block, periarticular local anesthetic infiltration would decrease the postoperative incidence of quadriceps weakness at 3 hours fivefold (ie, from 45% to 9%). METHODS: Sixty patients undergoing primary total hip arthroplasty under spinal anesthesia were randomly allocated to receive a pericapsular nerve group block (n=30) using 20 mL of adrenalized bupivacaine 0.50%, or periarticular local anesthetic infiltration (n=30) using 60 mL of adrenalized bupivacaine 0.25%. Both groups also received 30 mg of ketorolac, either intravenously (pericapsular nerve group block) or periarticularly (periarticular local anesthetic infiltration), as well as 4 mg of intravenous dexamethasone.Postoperatively, a blinded evaluator carried out sensory assessment and motor assessment (knee extension and hip adduction) at 3, 6 and 24 hours. Furthermore, the blinded observer also recorded static and dynamic pain scores at 3, 6, 12, 18, 24, 36 and 48 hours; time to first opioid request; cumulative breakthrough morphine consumption at 24 hours and 48 hours; opioid-related side effects; ability to perform physiotherapy at 6, 24 and 48 hours; as well as length of stay. RESULTS: There were no differences in quadriceps weakness at 3 hours between pericapsular nerve group block and periarticular local anesthetic infiltration (20% vs 33%; p=0.469). Furthermore, no intergroup differences were found in terms of sensory block or motor block at other time intervals; time to first opioid request; cumulative breakthrough morphine consumption; opioid-related side effects; ability to perform physiotherapy; and length of stay. Compared with pericapsular nerve group block, periarticular local anesthetic infiltration resulted in lower static pain scores (at all measurement intervals) and dynamic pain scores (at 3 and 6 hours). CONCLUSION: For primary total hip arthroplasty, pericapsular nerve group block and periarticular local anesthetic infiltration result in comparable rates of quadriceps weakness. However, periarticular local anesthetic infiltration is associated with lower static pain scores (especially during the first 24 hours) and dynamic pain scores (first 6 hours). Further investigation is required to determine the optimal technique and local anesthetic admixture for periarticular local anesthetic infiltration. TRIAL REGISTRATION NUMBER: NCT05087862.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Bravo D, Aliste J, Layera S, et al. Randomized clinical trial comparing pericapsular nerve group (PENG) block and periarticular local anesthetic infiltration for total hip arthroplasty. Reg Anesth Pain Med. 2023. PMID: 36797036. doi:10.1136/rapm-2023-104332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。